ABEO
ABEO
NASDAQ · Biotechnology

Abeona Therapeutics Inc

$5.68
-0.18 (-3.07%)
As of May 16, 2:02 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +148.1% upside
Low Target $7.81
Average Target $14.09
High Target $15.42
Current Price $5.68
Current
$5.68
Target
$14.09
$7.81 $14.09 avg $15.42
Scenario Analysis
Bear Case
$7.81
37.5%
Low target
Base Case
$14.09
+148.1%
Avg target
Bull Case
$15.42
+171.5%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$7.54
-24.7% from high
52-Week Low
$4.00
+42.0% from low
Target vs 52W High
$14.09
+86.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%